|
|
| March 24, 2012: Dr. Gregg W. Stone and Dr. Michael Gibson discuss: INFUSE-AMI - A 2x2 Factorial, Multicenter, Prospective, Randomized Ev |
Dr. Gregg W. Stone and Dr. Michael Gibson discuss: INFUSE-AMI - A 2x2 Factorial,
Multicenter, Prospective, Randomized Evaluation of Intracoronary Abciximab and Aspiration
Thrombectomy in Patients Undergoing Primary PCI for Anterior STEMI
Affiliation/Financial Relationship: Consulting Fees/Honoraria
Company: Abbott Vascular, Boston Scientific, Medtronic, Atrium, BMS-Sanofi, Merck,
Janssen, Eli Lilly, Daiichi Sankyo, The Medicines Company, Astra Zeneca
[ Download video ] |
|
No comments have been submitted
|